Business Description
OSI Systems, Inc. (OSIS) is a global company specializing in the design and production of advanced electronic systems and components. Its operations are structured across three distinct business segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division focuses on comprehensive screening and detection technologies. This includes systems for inspecting luggage, packages, cargo, vehicles, and individuals, alongside solutions for radiation, explosive, and narcotics detection. Key product lines are marketed under names such as Rapiscan Systems, AS&E, and Gatekeeper. Beyond hardware, the segment delivers integrated security screening services, including site planning, installation, user training, and ongoing technical support, with dedicated solutions offered via the S2 brand. Within the Healthcare segment, the company provides patient monitoring and diagnostic cardiology systems, complete with necessary supplies and accessories. These critical care solutions, branded predominantly as Spacelabs, are deployed in a range of medical environments, including hospitals (specifically critical care, emergency rooms, and surgical areas), physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment supplies various optoelectronic devices, marketed under brand names such as OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix. These devices cater to diverse high-tech sectors including aerospace, defense, avionics, medical imaging and diagnostics, biochemical analysis, pharmaceuticals, nanotechnology, telecommunications, construction, and homeland security. Additionally, it provides electronics manufacturing services (EMS) to both original equipment manufacturers (OEMs) and direct end-users, serving applications in medical, automotive, defense, aerospace, industrial, and consumer sectors through brands like OSI Electronics, APlus Products, Altaflex, and PFC. This segment also produces LCD displays for medical, industrial, and consumer electronics, along with flexible circuits tailored for OEM clients. Further expanding its offerings, the segment develops laser-based remote sensing technology, notably under the OSI Laserscan and Autosense brands, to identify and categorize vehicles in toll collection and traffic management systems. It also manufactures solid-state laser products, specifically for aerospace, defense, telecommunications, and medical applications, marketed under the OSI LaserDiode name. Established in 1987, OSI Systems is headquartered in Hawthorne, California.
Business History
Price Overview
Last updated: Jun 27, 2026 9:04am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 8.91
Total Equity: $951.08M
Shares: 17,178,000
Total Debt: $661.35M
Cash: $106.41M
EBITDA: $261.10M
Total Debt: $661.35M
Cash: $106.41M
Revenue: $1.71B
Revenue: $1.71B
Revenue: $1.71B
Total Equity: $951.08M
Tax Rate: 19.6%
Equity: $951.08M
Total Debt: $661.35M
Cash: $106.41M
Current Liabilities: $696.94M
Long-Term Debt: $463.50M
Total Debt: $661.35M
Total Equity: $951.08M
Shares: 17,178,000
Shares: 17,178,000
CapEx: -$41.50M
Shares: 17,178,000
Stock Price: $218.29
Net Income: $149.64M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 23, 2026 9:26pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.5B | $1.7B |
| Cost of Revenue | $727.0M | $758.8M | $847.9M | $1.0B | $1.1B |
| Gross Profit | $419.9M | $424.4M | $430.5M | $530.5M | $587.2M |
| Operating Expenses | $304.5M | $302.7M | $295.2M | $341.4M | $369.7M |
| Operating Income | $115.4M | $121.7M | $135.3M | $189.1M | $217.5M |
| Net Income | $74.0M | $115.3M | $91.8M | $128.2M | $149.6M |
| EBITDA | $159.2M | $168.0M | $173.8M | $231.3M | $261.1M |
| EPS | $4.12 | $6.57 | $5.45 | $7.55 | $8.91 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 9:26pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $80.6M | $64.2M | $76.8M | $95.4M | $106.4M |
| Total Current Assets | $709.4M | $746.1M | $839.9M | $1.2B | $1.4B |
| Total Assets | $1.4B | $1.4B | $1.6B | $1.9B | $2.2B |
| Current Liabilities | $344.8M | $614.0M | $571.7M | $814.6M | $696.9M |
| Long-Term Debt | $276.4M | $48.7M | $136.5M | $129.4M | $463.5M |
| Total Liabilities | $744.5M | $804.7M | $829.5M | $1.1B | $1.3B |
| Total Equity | $639.8M | $638.4M | $726.2M | $863.5M | $951.1M |
| Retained Earnings | $548.8M | $663.9M | $736.0M | $861.2M | $942.3M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 9:26pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $139.1M | $63.8M | $94.8M | -$87.5M | $97.6M |
| Capital Expenditure | -$29.5M | -$30.5M | -$32.3M | -$39.4M | -$41.5M |
| Free Cash Flow | $109.6M | $33.3M | $62.6M | -$126.9M | $56.1M |
| Acquisitions (net) | -$3.0M | -$14.1M | -$7.1M | -$9.0M | -$76.7M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$37.5M | -$111.6M | -$34.7M | $0 | -$80.4M |
| Net Change in Cash | $4.5M | -$16.4M | $12.5M | $18.6M | $11.1M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:00am (1h ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$1.7B $1.7B – $1.7B
|
$1.8B $1.8B – $1.8B
|
$1.9B $1.9B – $1.9B
|
$2.1B $2.1B – $2.1B
|
| EBITDA |
$245.3M $243.9M – $246.7M
|
$263.5M $260.8M – $265.0M
|
$279.1M $276.2M – $280.5M
|
$299.3M $299.3M – $299.3M
|
| Net Income |
$160.2M $158.2M – $162.3M
|
$179.0M $178.1M – $179.9M
|
$196.3M $190.7M – $201.9M
|
$225.6M $219.9M – $231.3M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 9:26pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +3.2% | +8.0% | +20.4% | +11.3% |
| Gross Profit Growth | +1.1% | +1.4% | +23.2% | +10.7% |
| Operating Income Growth | +5.5% | +11.1% | +39.8% | +15.1% |
| Net Income Growth | +55.8% | -20.4% | +39.6% | +16.8% |
| EBITDA Growth | +5.5% | +3.5% | +33.1% | +12.9% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 8:00am (1h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-04 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $281.84 | $5.6M |
| 2026-04-23 | Constantine W Paul | F-InKind | 65.00 | $292.52 | $19,014 |
| 2026-02-02 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $250.91 | $5.0M |
| 2025-12-31 | Constantine W Paul | A-Award | 55.00 | $192.73 | $10,600 |
| 2025-12-31 | SZE VICTOR S | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Morben Paul Keith | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Tropeano Michael | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | CHOPRA DEEPAK | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Okawa Cary M. | A-Award | 52.00 | $109.61 | $5,700 |
| 2025-12-31 | EDRICK ALAN I | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | MEHRA AJAY | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-23 | EDRICK ALAN I | G-Gift | 1,500.00 | $0.00 | $0 |
| 2025-12-13 | HAWKINS JAMES B | F-InKind | 15.00 | $259.44 | $3,892 |
| 2025-12-12 | SZE VICTOR S | G-Gift | 251.00 | $0.00 | $0 |
| 2025-12-11 | MEHRA AJAY | G-Gift | 3,000.00 | $0.00 | $0 |
| 2025-12-02 | Constantine W Paul | A-Award | 470.00 | $266.17 | $125,100 |
| 2025-11-22 | Okawa Cary M. | F-InKind | 26.00 | $251.10 | $6,529 |
| 2025-11-10 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $285.74 | $5.7M |
| 2025-11-07 | Morben Paul Keith | S-Sale | 416.00 | $279.10 | $116,106 |
| 2025-11-07 | HAWKINS JAMES B | S-Sale | 1,500.00 | $283.15 | $424,725 |
Narrative Economics
market-narrative step).